A Comparison of Local Infiltration Analgesia and Pecs Block for Analgesia in Mastectomy With Axillary Dissection – an Equivalence Study

Overview

The investigators aim to compare the quality of pain relief provided by local infiltration analgesia delivered by surgeon and Pecs block delivered by anaesthetist under ultrasound guidance for patients undergoing mastectomy with axillary dissection.

Full Title of Study: “A Comparison of Local Infiltration Analgesia and Pecs Block for Analgesia in Mastectomy With Axillary Dissection – an Equivalence Study”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Supportive Care
    • Masking: Double (Participant, Outcomes Assessor)
  • Study Primary Completion Date: July 16, 2019

Detailed Description

Total breast removal with armpit dissection may be a painful surgery. Pectoral nerve block (Pecs block) is common pain relief method used to reduce pain after breast surgery. The Pecs block is a pain relief method technique at targeted body part. The Pecs block numbs nerves which supply sensation to the upper chest wall, armpit and upper arm. This procedure is only possible under ultrasound guidance and is carried out by the anaesthetist (medical specialist who administers anaesthetics) after patients are put under general anaesthesia. Despite the advantages of Pecs block in pain management, this method is not always available to all patients due to various reasons. These reasons include the availability of ultrasound machine to facilitate the method, presence of anaesthetist to carry out the procedure and additional time required to perform this method in the operating theatre. Another method has been modified by our surgeons (medical specialist who performs surgery, a different specialty from anaesthetist) to achieve pain relief among patients undergoing breast removal surgery. This method is called local infiltration analgesia (LIA). The pain control is achieved by having the surgeons to deliver a pain control drug surgically during the breast removal operation. LIA could be a good pain control alternative when a Pecs block could not be performed. The investigators hope to compare the quality of pain relief provided by local infiltration analgesia delivered by surgeon and Pecs block delivered by anaesthetist under ultrasound guidance. The investigators hope to show that LIA delivered by surgeon is as effective as Pecs block in patients undergoing mastectomy with axillary dissection.

Interventions

  • Procedure: PECs Block
    • Regional Anaesthesia Technique ie Pectoralis Nerve Block under ultrasound guidance
  • Procedure: Local infiltration
    • LIA will be performed by surgeon during the operation. The upper skin flap will be raised in the standard manner for mastectomy. The lateral border of the major pectoralis muscle will then be visualised. A volume of 10 ml ropivacaine 0.5% will be delivered between the inter-fascial planes of the pectoral muscles. The lower skin flap will then be raised in the standard manner for mastectomy and the breast is raised off the pectoralis muscle exposing the serratus anterior muscle. A volume of 20 ml ropivacaine 0.5% will be delivered between the muscle planes of the serratus anterior and pectoralis minor muscles.

Arms, Groups and Cohorts

  • Active Comparator: PECs Block
    • Total local anaesthetic dose: 30ml ropivacaine 0.5% •Pecs block will be performed by anaesthetist using ultrasound guidance in plane approach: 10ml ropivacaine 0.5% will be delivered at the plane between pectoralis major and pectoralis minor, another 20ml ropivacaine 0.5% will be delivered in the plane between the pectoralis minor and serratus anterior muscles at the level of the third and fourth ribs
  • Placebo Comparator: Local Infiltration
    • LIA will be performed by surgeon during the operation. The upper skin flap will be raised in the standard manner for mastectomy. The lateral border of the major pectoralis muscle will then be visualised. A volume of 10 ml ropivacaine 0.5% will be delivered between the inter-fascial planes of the pectoral muscles. The lower skin flap will then be raised in the standard manner for mastectomy and the breast is raised off the pectoralis muscle exposing the serratus anterior muscle. A volume of 20 ml ropivacaine 0.5% will be delivered between the muscle planes of the serratus anterior and pectoralis minor muscles.

Clinical Trial Outcome Measures

Primary Measures

  • Total morphine consumption in 24 hour after surgery
    • Time Frame: 24 hour
    • Total morphine consumption in 24 hour after surgery

Secondary Measures

  • Duration of analgesia
    • Time Frame: 24 hours
    • time to first rescue analgesia after administration of block
  • Postoperative pain score.
    • Time Frame: 24 hours
    • Post op pain score will be assessed using a visual analogue scale (VAS, 0-10; 0 = no pain and 10 = worst imaginable pain). The vital signs and pain score will be recorded at 0, 0.5, 1, 2, 4, 6, 8, 12, and 24 h after surgery by the attending staff nurses blinded to the group allocation
  • Adverse Effects
    • Time Frame: 24 hours
    • Any adverse effects will be recorded (such as hypotension, respiratory depression, pruritus, shivering and urinary retention)
  • Postoperative nausea vomiting (PONV)
    • Time Frame: 24 hours
    • Postoperative nausea vomiting (PONV)
  • Intraoperative analgesia
    • Time Frame: 24 hours
    • total usage of IV Fentanyl intraoperatively
  • Operative time
    • Time Frame: 24 hrs
    • duration of surgery
  • Block performance time
    • Time Frame: 24 hours
    • time from needle insertion until needle exit from the skin
  • Block related complications
    • Time Frame: 24 hours
    • pneumothorax
  • Block related complications
    • Time Frame: 24 hours
    • vascular puncture
  • Block related complications
    • Time Frame: 24 hours
    • local anaesthetic toxicity
  • Post-operative complications
    • Time Frame: 24 hours
    • Bleeding
  • Post-operative complications
    • Time Frame: 24 hours
    • Wound infection

Participating in This Clinical Trial

Inclusion Criteria

  • Age above 21 years old – Able to give consent – Body weight > 50kg Exclusion Criteria:

  • Patient's refusal and inability to give consent – Allergy or contraindicated to local anaesthetics, paracetamol, NSAIDS or opioids – Background history of chronic pain – Bilateral procedures

Gender Eligibility: Female

Female

Minimum Age: 21 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Louis Ng Xiang Long
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Louis Ng Xiang Long, Co- Investigator – Changi General Hospital
  • Overall Official(s)
    • Kwee Lian Woon, Principal Investigator, Changi General Hospital
  • Overall Contact(s)
    • Kwee Lian Woon, +6581211037, Kwee_Lian_Woon@cgh.com.sg

References

Blanco R, Fajardo M, Parras Maldonado T. Ultrasound description of Pecs II (modified Pecs I): a novel approach to breast surgery. Rev Esp Anestesiol Reanim. 2012 Nov;59(9):470-5. doi: 10.1016/j.redar.2012.07.003. Epub 2012 Aug 29.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.